Humanwell Healthcare (600079.SH): Major shareholder filed for restructuring by creditors.
Renfu Medicine (600079.SH) announcement, the company received on September 24, 2024, from the controlling shareholder Wuhan Contemporary...
Humanwell Healthcare (600079.SH) announced that on September 24, 2024, the company received a notice letter from its controlling shareholder, Wuhan Contemporary Technology Industry Group Co., Ltd. ("Contemporary Technology"), regarding an application for reorganization. The company learned that Wuhan Credit Risk Management Financing Guarantee Co., Ltd. and Tianjin Shengzha Law Firm (hereinafter referred to as the "applicants") have applied to the Wuhan Intermediate People's Court in Hubei Province ("Wuhan Court" or "Court") for the reorganization of Contemporary Technology.
Related Articles
Bidding for Warner Bros. (WBD.US) enters a critical period, while Paramount Skydance (PSKY.US) speeds up the antitrust review process.
US Stock Market Move | Multiple departments issued letters to support the new consumption and financial consumption driving LexinFintech Holdings Ltd. Sponsored ADR Class A (LX.US) to rise by 6.04%.
Industry's First Rider Family Hospitalization Protection Implemented Meituan Upgrades Major Illness Care Plan Covering Over One Million Rider Families
Bidding for Warner Bros. (WBD.US) enters a critical period, while Paramount Skydance (PSKY.US) speeds up the antitrust review process.
US Stock Market Move | Multiple departments issued letters to support the new consumption and financial consumption driving LexinFintech Holdings Ltd. Sponsored ADR Class A (LX.US) to rise by 6.04%.
Industry's First Rider Family Hospitalization Protection Implemented Meituan Upgrades Major Illness Care Plan Covering Over One Million Rider Families
